2-hydroxyimipramine has been researched along with sotalol in 2 studies
Studies (2-hydroxyimipramine) | Trials (2-hydroxyimipramine) | Recent Studies (post-2010) (2-hydroxyimipramine) | Studies (sotalol) | Trials (sotalol) | Recent Studies (post-2010) (sotalol) |
---|---|---|---|---|---|
30 | 3 | 0 | 2,196 | 346 | 291 |
Protein | Taxonomy | 2-hydroxyimipramine (IC50) | sotalol (IC50) |
---|---|---|---|
Beta-2 adrenergic receptor | Homo sapiens (human) | 3.8169 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 7.1087 | |
Beta-3 adrenergic receptor | Homo sapiens (human) | 7.2 | |
Beta-2 adrenergic receptor | Canis lupus familiaris (dog) | 5.0667 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
2 other study(ies) available for 2-hydroxyimipramine and sotalol
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |